DexCom (DXCM) Misses Q3 EPS by 1c, Revenue Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $77.94 -0.49%
Revenue Growth %: +9.9%
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +9.9%
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $69 million versus the consensus estimate of $60.2 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Tompkins Financial (TMP) Tops Q3 EPS by 5c
- Venture Global rises after QatarEnergy supply talks reported
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
